• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

morita mami  盛田 麻美

ORCIDConnect your ORCID iD *help
… Alternative Names

Morita Mami  盛田 麻美

Less
Researcher Number 20647193
Affiliation (Current) 2025: 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん薬物療法研究部, 共同研究員
Affiliation (based on the past Project Information) *help 2022 – 2024: 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん薬物療法研究部, 共同研究員
2018 – 2021: 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん薬物療法研究部, 特任研究員
Review Section/Research Field
Principal Investigator
Basic Section 53030:Respiratory medicine-related
Except Principal Investigator
Basic Section 50010:Tumor biology-related / Medium-sized Section 50:Oncology and related fields
Keywords
Principal Investigator
代謝 / 小細胞肺がん / ビタミンC / 食事介入 / NAD / 肺がん / 前臨床 / 肺神経内分泌腫瘍 / Pkm / Pkm2 / Pkm1 … More
Except Principal Investigator
… More 代謝 / NAD / 鉄硫黄クラスター / PKM / がんターゲット治療 / がん Less
  • Research Projects

    (5 results)
  • Research Products

    (10 results)
  • Co-Researchers

    (6 People)
  •  小細胞肺がんの代謝脆弱性に着目した新規治療Principal Investigator

    • Principal Investigator
      盛田 麻美
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Miyagi Prefectural Hospital Organization Miyagi Cancer Center
  •  がんの代謝脆弱性をターゲットする新規治療とメカニズム

    • Principal Investigator
      田沼 延公
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Miyagi Prefectural Hospital Organization Miyagi Cancer Center
  •  Restriction of dietary vitamin reveals metabolic vulnerability of small cell lung cancerPrincipal Investigator

    • Principal Investigator
      Morita Mami
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Miyagi Prefectural Hospital Organization Miyagi Cancer Center
  •  The yin and yang of the Warburg effect of tumors.

    • Principal Investigator
      Tanuma Nobuhiro
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Review Section
      Medium-sized Section 50:Oncology and related fields
    • Research Institution
      Miyagi Prefectural Hospital Organization Miyagi Cancer Center
  •  A novel metabolism-targeting therapy of pulmonary neuroendocrine tumors.Principal Investigator

    • Principal Investigator
      Morita Mami
    • Project Period (FY)
      2018 – 2019
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Miyagi Prefectural Hospital Organization Miyagi Cancer Center

All 2022 2021 2020 2018

All Journal Article Presentation

  • [Journal Article] Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B).2022

    • Author(s)
      Tsubata Y, Watanabe K, Saito R, Nakamura A, Yoshioka H, Morita M, Honda R, Kanaji N, Ohizumi S, Jingu D, Nakagawa T, Nakazawa K, Mouri A, Takeuchi S, Furuya N, Akazawa Y, Miura K, Ichihara E, Maemondo M, Morita S, Kobayashi K, Isobe T
    • Journal Title

      Int J Clin Oncol.

      Volume: 27(1) Issue: 1 Pages: 112-120

    • DOI

      10.1007/s10147-021-02043-2

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20K17203
  • [Journal Article] Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402.2021

    • Author(s)
      Miyauchi E, Tanaka H, Nakamura A, Harada T, Nakagawa T, Morita M, Jingu D, Kuda T, Gamou S, Saito R, Inoue A.
    • Journal Title

      Thorac Cancer.

      Volume: 12(21) Issue: 21 Pages: 2886-2893

    • DOI

      10.1111/1759-7714.14149

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K17203
  • [Journal Article] Dietary intervention as a therapeutic for cancer.2021

    • Author(s)
      Morita M, Kudo K, Shima H, Tanuma N
    • Journal Title

      Cancer Sci

      Volume: 112 Issue: 2 Pages: 498-504

    • DOI

      10.1111/cas.14777

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20K17203
  • [Journal Article] Comparison of the ischemic and non-ischemic lung cancer metabolome reveals hyper activity of the TCA cycle and autophagy.2020

    • Author(s)
      Kikuchi N, Soga T, Nomura M, Sato T, Sakamoto Y, Tanaka R, Abe J, Morita M, Shima H, Okada Y, Tanuma N
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 530 Issue: 1 Pages: 285-291

    • DOI

      10.1016/j.bbrc.2020.07.082

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20K17203, KAKENHI-PROJECT-20K17768
  • [Journal Article] Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer2020

    • Author(s)
      Kudo Kei、Nomura Miyuki、Sakamoto Yoshimi、Ito Shigemi、Morita Mami、Kawai Masaaki、Yamashita Yoji、Ito Kiyoshi、Yamada Hidekazu、Shima Hiroshi、Yaegashi Nobuo、Tanuma Nobuhiro
    • Journal Title

      FEBS Letters

      Volume: 594 Issue: 9 Pages: 1379-1388

    • DOI

      10.1002/1873-3468.13736

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K09469, KAKENHI-PROJECT-17K07187, KAKENHI-PROJECT-19K09109, KAKENHI-PROJECT-18K09243, KAKENHI-PROJECT-17K07231, KAKENHI-PROJECT-18K15965
  • [Journal Article] ピルビン酸キナーゼMのアイソフォームPkm1はがんの増殖を細胞自律的に促進する2018

    • Author(s)
      盛田麻美・佐藤 卓・田沼延公
    • Journal Title

      First Author's

      Volume: - Pages: 038

    • DOI

      10.7875/first.author.2018.038

    • Data Source
      KAKENHI-PROJECT-18K15965, KAKENHI-PROJECT-17K19620
  • [Presentation] Restriction of the dietary niacin enhances NAD-targeting therapy in mice2022

    • Author(s)
      Miyuki Nomura, Tomoyoshi Soga, Shusuke Akamatsu, Mami Morita, Yoji Yamashita, Hiroshi Shima, Hidekazu Yamada, Taku Sato, Nobuhiro Tanuma
    • Organizer
      第81回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-20K17203
  • [Presentation] NAD dependence of small-cell lung and prostate cancers2022

    • Author(s)
      Nobuhiro Tanuma, Shuko Miya-hara, Miyuki Nomura, Tomoyoshi Soga, Shusuke Akamatsu, Mami Morita, Yoji Yamashita, Hiroshi Shima, Hidekazu Yamada, Taku Sato,
    • Organizer
      第81回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-20K17203
  • [Presentation] Systemic niacin metabolism that limits efficacy of NAD-targeted therapy in cancer2022

    • Author(s)
      野村美有樹、大内麻衣、伊藤しげみ、盛田麻美、菊池直彦、佐藤卓、 中川崇、田沼延公
    • Organizer
      第95回 日本生化学会大会
    • Data Source
      KAKENHI-PROJECT-20K17203
  • [Presentation] NAD biogenesis is a targetable vulnerability of small-cell lung and prostate cancers2022

    • Author(s)
      大内麻衣、宮原周子、野村美有樹、坂本良美、伊藤しげみ、盛田麻美、佐藤卓、菊池直彦、田沼延公
    • Organizer
      第95回 日本生化学会大会
    • Data Source
      KAKENHI-PROJECT-20K17203
  • 1.  Tanuma Nobuhiro (40333645)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 1 results
  • 2.  佐藤 卓 (90814541)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 3.  安田 純 (00281684)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  島 礼 (10196462)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  海野 雄加 (30433212)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  山下 洋二
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi